Nantong Guangyuan Chemical

Nantong Guangyuan Chemical Co., Ltd. (trading as GGPeps; ggpeps.net) is a peptide supplier based in Nantong, Jiangsu, China, trading under several designations including GGPeps and GYC, operating a distributed warehouse network and with a substantial associated third-party testing record.^[1][2]

The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

The organisation operates from Nantong, Jiangsu, within the Yangtze delta manufacturing belt.^[1] No incorporation year is documented in sources available to this wiki and none is asserted here.

It trades under several designations — a registered chemical-company name and at least two shorter trading names — and purchaser reports use them interchangeably.^[5] The multiplicity is the most practically consequential fact about the organisation for a reader attempting verification, since material discussed under one designation may not obviously be the same organisation as material discussed under another. The article lists all of them in its opening sentence for that reason.

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe a distributed warehouse arrangement, with orders fulfilled from regional stock as well as from China, and correspondingly variable transit times and customs exposure.^[5] Certificate content in the submitted set has been middling: purity and appearance consistently, water and method inconsistently.^[6]

A warehouse network introduces a documentary question that single-origin shipping does not: material held in a regional warehouse has a storage history between manufacture and dispatch that the certificate does not describe, and a certificate dated at manufacture says nothing about the interval since.^[5]

The catalogue is conventional. The warehouse arrangement, not the range, is what distinguishes the organisation operationally.^[5]

The associated report set is among the larger on the wiki, second only to the Wuhan entity.^[5] Reported area percent figures have mostly clustered in the high nineties with a modest tail below.

The interpretive limits set out at length on Wuhan Wansheng Biotechnology apply here in the same terms and are not restated. One limitation is specific to this organisation: because material may have been held in a regional warehouse for an undocumented interval, a disagreement between a certificate dated at manufacture and a report dated at receipt may reflect elapsed storage rather than the material as manufactured. Nothing in the available documentation permits distinguishing the two.^[5][6]

The PeptidePedia tally records 1,131 self-reported submissions to July 2026 — the second-largest count in this group. Recurring positive themes are delivery speed from regional stock and catalogue availability; recurring complaints concern the multiple trading names, documentation consistency, and uncertainty about how long material had been in storage.^[4] Self-selected; reception rather than quality.^[4]

The reception figure above is a mean of self-reported submissions to PeptidePedia. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

Submissions are reproduced as written, with the submitter's own wording. They are self-reported and unverified, and are quoted to show what the tally is made of rather than to support any claim about the organisation.

Their raw material tested 97.6% against a reseller vial of nominally the same compound at 97.4%. Going direct is the whole argument.

Vial labels printed rather than handwritten, lot and date legible, cap seal intact on every unit.

Custom synthesis quote came back with a realistic timeline and they beat it. Purity on delivery matched the signed spec.

Their warehouse in the United Kingdom had the MOTS-c 10 mg in stock and it shipped the same afternoon. Tracking never left the country.

They report purity by RP-HPLC with the wavelength stated and peptide content separately. Two different numbers, correctly separated.

Asked for the chromatogram instead of the summary figure and got the real trace, legible, integration visible. They send it without hesitating.

Tenth order from them, all mazdutide 5 mg. Sent one vial from each to Janoshik and the whole set landed inside half a point of each other. That flatness is exactly what I pay for.

Certificate claimed 98.7% on lot LOT-26-833. Janoshik came back 98.9%. On an independent column that is as close to agreement as this gets.

Weighed 9 vials from the ipamorelin 5 mg order against label. Every one inside 2% of stated mass. Fill consistency is harder than purity and they have it.

Costed them per mg against three other suppliers on the same cagrilintide 5 mg spec. Competitive on price and clearly ahead on documentation.

Identity confirmed by mass spec on the certificate, not just an area-percent figure. Both questions answered on one page.

Asked them to hold an order until I confirmed a lot number and they did, without fuss and without a restocking charge.

Regional stock makes the difference — dispatched within the Netherlands, day 2, cold pack still hard on arrival.

Dispatched from their warehouse in Australia rather than from the factory, so the survodutide 5 mg was with me on day 3.

The certificate for lot LOT-24-341 carried method, wavelength, water content and an itemised related-substances table. Complete on the first pass.

Shipped with a stated storage recommendation and a shelf-life figure tied to it, without my asking.

Their warehouse in the United Kingdom carries the lines I reorder, so there is no wait on a factory run. Day 5 every time.

PeptideMeter has now seen 6 of their lots through me. Not one has come back outside spec.

Ordered on a Monday from their warehouse in the Netherlands and it was here by day 2. That is the whole case for regional stock.

The tirzepatide 15 mg arrived on day 4 with the cold pack intact and the seal unbroken. Straightforward, exactly as described.

Asked a genuinely technical question about pre-dispatch storage and got a reply with numbers in it, inside 4 hours.

Reordered on the strength of the last one and got an identical result. Repeatability is the product.

First order, deliberately small, selank 10 mg only. Documentation, transit and a PeptideMeter result at 98.8% all checked out, so the next one will not be small.

Support answered on a Sunday, correctly, with the batch record attached. That is well beyond what I expected.

Submitted the BPC-157 10 mg to Medutest blind, without telling them the source. 98.7% against a stated 98.3%. The number holds up when nobody knows whose vial it is.

No customs paperwork, no import wait — it came from their stock in Germany and arrived day 4.

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,^[7] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.^[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

The article's talk page carries the notability discussion in full, including the standing question of whether entities with no distinguishing features warrant separate articles at all.

• Visit GGPeps

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.